Single-dose pharmacokinetics of ceftriaxone in infants and young children.
AUTOR(ES)
Schaad, U B
RESUMO
The pharmacokinetics of ceftriaxone were studied in five infants (7 to 15 months old) and five young children (24 to 70 months old). Both groups received a single 50-mg/kg dose in an intravenous infusion over 5 min. No major pharmacokinetic differences were observed between the two populations. The total (bound plus unbound) plasma concentration-versus-time data could be described in each case by a biexponential equation. Changes in renal clearance indicated time- and dose- dependent pharmacokinetic behavior. The fraction excreted unchanged in the urine (fu) and the biological half-life (t 1/2 (beta)) were, however, dose independent. The average values were 47% for fu (0 to 12 h) and 6.5 for T 1/2 (beta). Weight-corrected total systemic clearance was C1TS = 0.71 ml/min per kg; volume of distribution was VD (beta) = 394 mg/kg. The data support intravenous administration of 50 mg of ceftriaxone per kg of body weight every 12 h in assessing its activity against Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis in postneonatal-stage pediatric patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181867Documentos Relacionados
- Single-Dose Pharmacokinetics of Ceftriaxone in Infants and Young Children
- Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.
- Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children.
- Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
- Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.
